The neurotensin system is altered in the temporal lobe of AD patients (Gahete et al, 2010), and APP/PS1 mice microinjected with Neurotensin show improved spatial memory functions and neuronal excitability (Xiao et al, 2014). This evidence concerns the gene APP and Alzheimer disease.